Healthcare (Oct 2022)
Fighting Cancer around the World: A Framework for Action
- Denis Horgan,
- Rizwana Mia,
- Tosan Erhabor,
- Yosr Hamdi,
- Collet Dandara,
- Jonathan A. Lal,
- Joel Fokom Domgue,
- Oladimeji Ewumi,
- Teresia Nyawira,
- Salomé Meyer,
- Dominique Kondji,
- Ngiambudulu M. Francisco,
- Sadakatsu Ikeda,
- Chai Chuah,
- Roselle De Guzman,
- Anupriya Paul,
- Krishna Reddy Nallamalla,
- Woong-Yang Park,
- Vijay Tripathi,
- Ravikant Tripathi,
- Amber Johns,
- Mohan P. Singh,
- Maude E. Phipps,
- France Dube,
- Kate Whittaker,
- Deborah Mukherji,
- Hadi Mohamad Abu Rasheed,
- Marta Kozaric,
- Joseph A. Pinto,
- Stephen Doral Stefani,
- Federico Augustovski,
- Maria Eugenia Aponte Rueda,
- Ricardo Fujita Alarcon,
- Hugo A. Barrera-Saldana
Affiliations
- Denis Horgan
- European Alliance for Personalised Medicine, 1040 Brussels, Belgium
- Rizwana Mia
- Grants, Innovation & Product Development, South African Medical Research Council, Francie Van Zijl Drive, Parow Valley, Cape Town 7505, South Africa
- Tosan Erhabor
- Medical Laboratory Science Council of Nigeria (MLSCN), Durumi, Abuja 900110, Nigeria
- Yosr Hamdi
- Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis 1002, Tunisia
- Collet Dandara
- Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Observatory, Cape Town 7925, South Africa
- Jonathan A. Lal
- Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
- Joel Fokom Domgue
- Departments of Epidemiology, and Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Centre, Houston, TX 77030, USA
- Oladimeji Ewumi
- Freelance Health Care, Life Sciences, Medical Artificial Intelligence Content Writer, Lagos 100253, Nigeria
- Teresia Nyawira
- National Commission for Science, Technology and Innovation in Kenya (NACOSTI), Nairobi 00100, Kenya
- Salomé Meyer
- Cancer Alliance, Cape Town 7700, South Africa
- Dominique Kondji
- Health & Development Communication, Building Capacities for Better Health in Africa, Yaounde P.O. Box 2032, Cameroon
- Ngiambudulu M. Francisco
- Grupo de Investigação Microbiana e Imunológica, Instituto Nacional de Investigação em Saúde (National Institute for Health Research), Luanda 3635, Angola
- Sadakatsu Ikeda
- Department of Precision Cancer Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
- Chai Chuah
- Singularity University, P.O. Box 165, Gold Coast, QLD 4227, Australia
- Roselle De Guzman
- Oncology and Pain Management Section, Manila Central University–Filemon D. Tanchoco Medical Foundation Hospital, Caloocan 1400, Philippines
- Anupriya Paul
- Department of Mathematics and Statistics, Faculty of Science, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
- Krishna Reddy Nallamalla
- ACCESS Health India, Hyderabad 500086, India
- Woong-Yang Park
- Samsung Genome Institute, Samsung Medical Centre, Sungkyunkwan University, Seoul 06351, Korea
- Vijay Tripathi
- Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
- Ravikant Tripathi
- Ministry of Labor, Health Department Government of India, New Delhi 110001, India
- Amber Johns
- Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Cancer Division, Sydney, NSW 2010, Australia
- Mohan P. Singh
- Centre of Biotechnology, University of Allahabad, Allahabad 211002, India
- Maude E. Phipps
- Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya 47500, Selangor, Malaysia
- France Dube
- Astra Zeneca, 1800 Concord Pike, Wilmington, DE 19803, USA
- Kate Whittaker
- Cancer Council Australia, Sydney, NSW 2000, Australia
- Deborah Mukherji
- Global Health Institute, American University of Beirut, Beirut VFXP+7QF, Lebanon
- Hadi Mohamad Abu Rasheed
- Qatar Cancer Society, Doha 22944, Qatar
- Marta Kozaric
- European Alliance for Personalised Medicine, 1040 Brussels, Belgium
- Joseph A. Pinto
- Centre for Basic and Translational Research, Auna Ideas, Lima 15036, Peru
- Stephen Doral Stefani
- UNIMED RS, Porto Alegre 90040-180, Brazil
- Federico Augustovski
- Health Technology Assessment and Health Economics, Department of the Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires C1056ABH, Argentina
- Maria Eugenia Aponte Rueda
- Venezuelan Breast Cancer Research and Education Foundation, Caracas 1060, Venezuela
- Ricardo Fujita Alarcon
- Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima 15024, Peru
- Hugo A. Barrera-Saldana
- Innbiogem SC/Vitagenesis SA at National Laboratory for Services of Research, Development, and Innovation for the Pharma and Biotech Industries (LANSEIDI) of CONACyT Vitaxentrum Group, Monterrey 64630, Mexico
- DOI
- https://doi.org/10.3390/healthcare10112125
- Journal volume & issue
-
Vol. 10,
no. 11
p. 2125
Abstract
Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe–and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients’ engagement, and efforts for a better understanding of cancer.
Keywords
